Table 10.
Types | Pre-pandemic I | Pre-pandemic II | During-pandemic | Post-pandemic | Total | Ratio/% | ||||
---|---|---|---|---|---|---|---|---|---|---|
case | ratio/% | case | ratio/% | case | ratio/% | case | ratio/% | |||
UDE | 2 | 100 | 2 | 25 | 11 | 57.89 | 2 | 50 | 17 | 51.52 |
OLI | 0 | 0 | 4 | 50 | 8 | 42.11 | 1 | 25 | 13 | 39.39 |
DDI | 0 | 0 | 2 | 25 | 0 | 0 | 0 | 0 | 2 | 6.06 |
MESP | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 25 | 1 | 3.03 |
Total | 2 | 100 | 8 | 100 | 19 | 100 | 4 | 100 | 33 | 100 |
OLI, off-label indications.
MESP, medication errors of special population.
DDI, drug-drug interaction.
UDE, usage and dosage errors.